UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
F O R M 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2025
TAT TECHNOLOGIES LTD.
(Name of Registrant)
Hamelacha 5, Netanya 4250540, Israel
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ☐ No ☒
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ____________
|
Item/Exhibit No.
|
Description
|
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
TAT TECHNOLOGIES LTD. (Registrant)
By: /s/ Ehud Ben-Yair Ehud Ben-Yair Chief Financial Officer |
Date: November 12, 2025
| • |
Revenues increased by 14.3% to $46.2 million compared to $40.5 million for the third quarter of 2024. For the nine months of 2025 revenues increased by 18.4% to $131.5 million compared to $111.1
million in the nine months of 2024.
|
| • |
Gross profit increased by 36.8% to $11.6 million (25.1% of revenues) compared to $8.5 million (21.0% of revenues) for the third quarter of 2024. For the nine months of 2025 gross profit increased by
37.6% to $32.4 million (24.6% of revenues) compared to $23.5 million (21.2% of revenues) in the nine months of 2024.
|
| • |
Operating Income increased by 52.6% to $5.3 million (11.4% of revenues) compared to $3.4 million (8.5% of revenues) for the third quarter of 2024. For the nine months of 2025 operating income
increased by 65.3% to $13.9 million (10.5% of revenues) compared to $8.4 million (7.6% of revenues) in the nine months of 2024.
|
| • |
Net Income increased by 69.0% to $4.8 million compared to $2.9 million for the third quarter of 2024. For the nine months of 2025 net income increased by 59.3% to $12.1 million compared to $7.6
million in the nine months of 2024.
|
| • |
Adjusted EBITDA increased by 34.4% to $6.8 million (14.6% of revenues) compared to $5.0 million (12.4% of revenues) for the third quarter of 2024. Adjusted EBITDA for the nine months of 2025
increased by 42.2% to $18.6 million (14.1% of revenues) compared to $13.1 million (11.8% of revenues) in the nine months of 2024.
|
| • |
Cash flow provided by operating activities for the three and nine months ended September 30, 2025, was $7.5 million and $9.4 million, respectively, compared to cash flows provided by operating
activities of $2.7 million and cash flows used in operating activities of $(4.8) million for the three and nine months ended September 30, 2024, respectively.
|
| • |
Conference call
|
|
September 30,
|
December 31,
|
|||||||
|
2025
|
2024
|
|||||||
|
ASSETS
|
||||||||
|
CURRENT ASSETS:
|
||||||||
|
Cash and cash equivalents
|
$
|
47,094
|
$
|
7,129
|
||||
|
Accounts receivable, net of allowance for credit losses of $321
and $400 as of September 30, 2025, and December 31, 2024, respectively
|
33,330
|
29,697
|
||||||
|
Inventory
|
78,171
|
68,540
|
||||||
|
Prepaid expenses and other current assets
|
6,301
|
7,848
|
||||||
|
Total current assets
|
164,896
|
113,214
|
||||||
|
NON-CURRENT ASSETS:
|
||||||||
|
Property, plant and equipment, net
|
46,172
|
41,576
|
||||||
|
Operating lease right of use assets
|
5,363
|
2,282
|
||||||
|
Intangible assets, net
|
1,528
|
1,553
|
||||||
|
Investment in affiliates
|
4,460
|
2,901
|
||||||
|
Funds in respect of employee rights upon retirement
|
736
|
654
|
||||||
|
Deferred income taxes
|
683
|
877
|
||||||
|
Restricted deposit
|
297
|
305
|
||||||
|
Total non-current assets
|
59,239
|
50,148
|
||||||
|
Total assets
|
$
|
224,135
|
$
|
163,362
|
||||
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
||||||||
|
CURRENT LIABILITIES:
|
||||||||
|
Current maturities of long-term loans
|
$
|
2,151
|
$
|
2,083
|
||||
|
Short-term loans
|
-
|
4,350
|
||||||
|
Accounts payable
|
16,898
|
12,158
|
||||||
|
Accrued expenses and other
|
16,709
|
18,594
|
||||||
|
Current maturities of operating lease liabilities
|
1,358
|
939
|
||||||
|
Total current liabilities
|
37,116
|
38,124
|
||||||
|
NON-CURRENT LIABILITIES:
|
||||||||
|
Long-term loans
|
9,884
|
10,938
|
||||||
|
Liability in respect of employee rights upon retirement
|
1,109
|
986
|
||||||
|
Deferred tax liabilities
|
1,272
|
-
|
||||||
|
Operating lease liabilities
|
4,066
|
1,345
|
||||||
|
Total non-current liabilities
|
16,331
|
13,269
|
||||||
|
COMMITMENTS AND CONTINGENCIES (NOTE 4)
|
-
|
-
|
||||||
|
Total liabilities
|
53,447
|
51,393
|
||||||
|
SHAREHOLDERS’ EQUITY:
|
||||||||
|
Ordinary shares of NIS 0 par value at September 30, 2025 and at December 31, 2024, respectively
Authorized: 15,000,000 shares at September 30, 2025 and 13,000,000 at December 31, 2024; Issued:
13,225,110 and 11,214,831 shares at September 30, 2025 and at December 31, 2024, respectively; Outstanding:
12,950,637 and 10,940,358 shares at September 30, 2025 and at December 31, 2024, respectively
|
-
|
-
|
||||||
|
Additional paid-in capital
|
135,745
|
89,697
|
||||||
|
Treasury stock at cost
|
(2,088
|
)
|
(2,088
|
)
|
||||
|
Accumulated other comprehensive income (loss)
|
499
|
(76
|
)
|
|||||
|
Retained earnings
|
36,532
|
24,436
|
||||||
|
Total shareholders' equity
|
170,688
|
111,969
|
||||||
|
Total liabilities and shareholders' equity
|
$
|
224,135
|
$
|
163,362
|
||||
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Revenues:
|
||||||||||||||||
|
Products
|
$
|
12,617
|
$
|
12,164
|
$
|
37,804
|
$
|
35,831
|
||||||||
|
Services
|
33,618
|
28,295
|
93,677
|
75,241
|
||||||||||||
|
46,235
|
40,459
|
131,481
|
111,072
|
|||||||||||||
|
Cost of goods:
|
||||||||||||||||
|
Products
|
9,170
|
8,535
|
26,613
|
25,194
|
||||||||||||
|
Services
|
25,464
|
23,443
|
72,488
|
62,347
|
||||||||||||
|
34,634
|
31,978
|
99,101
|
87,541
|
|||||||||||||
|
Gross profit
|
11,601
|
8,481
|
32,380
|
23,531
|
||||||||||||
|
Operating expenses:
|
||||||||||||||||
|
Research and development, net
|
323
|
326
|
887
|
946
|
||||||||||||
|
Selling and marketing
|
1,993
|
1,994
|
6,106
|
5,647
|
||||||||||||
|
General and administrative
|
4,025
|
2,715
|
11,522
|
8,940
|
||||||||||||
|
Other income
|
-
|
-
|
-
|
(390
|
)
|
|||||||||||
|
6,341
|
5,035
|
18,515
|
15,143
|
|||||||||||||
|
Operating income
|
5,260
|
3,446
|
13,865
|
8,388
|
||||||||||||
|
Interest expenses
|
(176
|
)
|
(420
|
)
|
(835
|
)
|
(1,183
|
)
|
||||||||
|
Other financial income (expenses), net
|
206
|
(315
|
)
|
(293
|
)
|
(308
|
)
|
|||||||||
|
Income before taxes on income (taxes benefit)
|
5,290
|
2,711
|
12,737
|
6,897
|
||||||||||||
|
Provision for taxes on income (taxes benefit)
|
821
|
15
|
1,624
|
(94
|
)
|
|||||||||||
|
Profit before share of equity investment
|
4,469
|
2,696
|
11,113
|
6,991
|
||||||||||||
|
Share in profits of equity investment of affiliated companies
|
372
|
169
|
983
|
601
|
||||||||||||
|
Net income
|
$
|
4,841
|
$
|
2,865
|
$
|
12,096
|
$
|
7,592
|
||||||||
|
Earnings per share
|
||||||||||||||||
|
Basic
|
$
|
0.37
|
$
|
0.27
|
$
|
1.03
|
$
|
0.73
|
||||||||
|
Diluted
|
$
|
0.37
|
$
|
0.26
|
$
|
1.02
|
$
|
0.69
|
||||||||
|
Weighted average number of shares outstanding
|
||||||||||||||||
|
Basic
|
12,911,050
|
10,609,867
|
11,776,747
|
10,462,012
|
||||||||||||
|
Diluted
|
13,078,467
|
10,829,749
|
11,904,044
|
11,055,263
|
||||||||||||
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Net income
|
$
|
4,841
|
$
|
2,865
|
$
|
12,096
|
$
|
7,592
|
||||||||
|
Other comprehensive income (loss), net
|
||||||||||||||||
|
Net unrealized losses from derivatives
|
-
|
-
|
-
|
(27
|
)
|
|||||||||||
|
Change in foreign currency translation adjustments
|
(102
|
)
|
(43
|
)
|
575
|
121
|
||||||||||
|
Total comprehensive income
|
$
|
4,739
|
$
|
2,822
|
$
|
12,671
|
$
|
7,686
|
||||||||
|
Share capital
|
Additional paid-in capital
|
Accumulated
other comprehensive income (loss)
|
Treasury shares
|
Retained earnings
|
Total equity
|
|||||||||||||||||||||||
|
Number of shares issued
|
Amount
|
|||||||||||||||||||||||||||
|
BALANCE AT DECEMBER 31, 2023
|
10,377,085
|
$
|
3,140
|
$
|
76,335
|
$
|
27
|
$
|
(2,088
|
)
|
$
|
13,269
|
$
|
90,683
|
||||||||||||||
|
CHANGES DURING THE NINE MONTHS ENDED SEPTEMBER 30, 2024:
|
||||||||||||||||||||||||||||
|
Comprehensive income
|
-
|
-
|
-
|
94
|
-
|
7,592
|
7,686
|
|||||||||||||||||||||
|
Exercise of option
|
84,006
|
12
|
(12
|
)
|
-
|
-
|
-
|
-
|
||||||||||||||||||||
|
Cancellation of par value
|
-
|
(3,152
|
)
|
3,152
|
-
|
-
|
-
|
-
|
||||||||||||||||||||
|
Issuance of common shares on public offering, net of issuance costs of $152
|
673,340
|
-
|
9,923
|
-
|
-
|
-
|
9,923
|
|||||||||||||||||||||
|
Share based compensation
|
-
|
-
|
210
|
-
|
-
|
-
|
210
|
|||||||||||||||||||||
|
BALANCE AT SEPTEMBER 30, 2024
|
11,134,431
|
-
|
89,608
|
121
|
(2,088
|
)
|
20,861
|
108,502
|
||||||||||||||||||||
|
BALANCE AT DECEMBER 31, 2024
|
11,214,831
|
-
|
89,697
|
(76
|
)
|
(2,088
|
)
|
24,436
|
111,969
|
|||||||||||||||||||
|
CHANGES DURING THE NINE MONTHS ENDED SEPTEMBER 30, 2025:
|
||||||||||||||||||||||||||||
|
Comprehensive income
|
-
|
-
|
-
|
575
|
-
|
12,096
|
12,671
|
|||||||||||||||||||||
|
Exercise of option
|
142,981
|
-
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||||||||||
|
Issuance of common shares on public offering, net of issuance costs of $2,769
|
1,625,000
|
-
|
39,415
|
-
|
-
|
-
|
39,415
|
|||||||||||||||||||||
|
Exercise of the underwriters' option on public offering, net of issuance costs of $413
|
242,298
|
-
|
5,953
|
-
|
-
|
-
|
5,953
|
|||||||||||||||||||||
|
Share based compensation
|
-
|
-
|
680
|
-
|
-
|
-
|
680
|
|||||||||||||||||||||
|
BALANCE AT SEPTEMBER 30, 2025
|
13,225,110
|
-
|
$
|
135,745
|
$
|
499
|
$
|
(2,088
|
)
|
$
|
36,532
|
$
|
170,688
|
|||||||||||||||
|
Share capital
|
Additional paid-in capital
|
Accumulated
other comprehensive income
|
Treasury shares
|
Retained earnings
|
Total equity
|
|||||||||||||||||||||||
|
Number of shares issued
|
Amount
|
|||||||||||||||||||||||||||
|
BALANCE AT JUNE 30, 2024
|
10,426,194
|
$
|
3,152
|
$
|
76,512
|
$
|
164
|
$
|
(2,088
|
)
|
$
|
17,996
|
$
|
95,736
|
||||||||||||||
|
CHANGES DURING THE THREE MONTHS ENDED SEPTEMBER 30, 2024:
|
||||||||||||||||||||||||||||
|
Comprehensive income
|
34,897
|
-
|
-
|
(43
|
)
|
2,865
|
2,822
|
|||||||||||||||||||||
|
Exercise of option
|
(3,152
|
)
|
3,152
|
-
|
-
|
-
|
-
|
|||||||||||||||||||||
|
Issuance of common shares net of issuance costs of $152
|
673,340
|
-
|
9,923
|
-
|
-
|
-
|
9,923
|
|||||||||||||||||||||
|
Share based compensation
|
-
|
21
|
-
|
-
|
-
|
21
|
||||||||||||||||||||||
|
BALANCE AT SEPTEMBER 30, 2024
|
11,134,431
|
-
|
89,608
|
121
|
(2,088
|
)
|
20,861
|
108,502
|
||||||||||||||||||||
|
BALANCE AT JUNE 30, 2025
|
13,161,762
|
-
|
135,578
|
600
|
(2,088
|
)
|
31,691
|
165,781
|
||||||||||||||||||||
|
CHANGES DURING THE THREE MONTHS ENDED SEPTEMBER 30, 2025:
|
||||||||||||||||||||||||||||
|
Comprehensive income
|
-
|
-
|
-
|
(101
|
)
|
-
|
4,841
|
4,740
|
||||||||||||||||||||
|
Exercise of stock option
|
63,348
|
-
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||||||||||
|
Share based compensation
|
-
|
-
|
167
|
-
|
-
|
-
|
167
|
|||||||||||||||||||||
|
BALANCE AT SEPTEMBER 30, 2025
|
13,225,110
|
-
|
$
|
135,745
|
$
|
499
|
$
|
(2,088
|
)
|
$
|
36,532
|
$
|
170,688
|
|||||||||||||||
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||||||||||
|
Net income
|
$
|
4,841
|
$
|
2,865
|
$
|
12,096
|
$
|
7,592
|
||||||||
|
Adjustments to reconcile net income to net cash used in operating activities:
|
||||||||||||||||
|
Depreciation and amortization
|
1,249
|
1,514
|
3,762
|
4,319
|
||||||||||||
|
Non-cash financial (income) expenses
|
126
|
220
|
634
|
(266
|
)
|
|||||||||||
|
Change in allowance for credit losses
|
(104
|
)
|
(40
|
)
|
(79
|
)
|
-
|
|||||||||
|
Share in profits of equity investment of affiliated companies
|
(372
|
)
|
(169
|
)
|
(983
|
)
|
(601
|
)
|
||||||||
|
Share based compensation
|
167
|
21
|
680
|
210
|
||||||||||||
|
Gain on disposal of property, plant and equipment
|
-
|
-
|
-
|
(355
|
)
|
|||||||||||
|
Deferred income taxes, net
|
884
|
12
|
1,466
|
(91
|
)
|
|||||||||||
|
Changes in operating assets and liabilities:
|
||||||||||||||||
|
Increase in trade accounts receivable
|
(960
|
)
|
(3,456
|
)
|
(3,554
|
)
|
(9,706
|
)
|
||||||||
|
Decrease (increase) in prepaid expenses and other current assets
|
281
|
(555
|
)
|
1,464
|
(838
|
)
|
||||||||||
|
Increase in inventory
|
(1,757
|
)
|
(5,112
|
)
|
(9,052
|
)
|
(10,655
|
)
|
||||||||
|
Increase in trade accounts payable
|
1,334
|
3,825
|
4,740
|
2,916
|
||||||||||||
|
Increase (decrease) in accrued expenses and other
|
1,806
|
3,665
|
(1,765
|
)
|
2,618
|
|||||||||||
|
Net cash provided by (used in) operating activities
|
7,495
|
2,790
|
9,409
|
(4,857
|
)
|
|||||||||||
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
||||||||||||||||
|
Purchase of property and equipment
|
(2,743
|
)
|
(1,621
|
)
|
(8,910
|
)
|
(3,588
|
)
|
||||||||
|
Proceeds from sale of property and equipment
|
-
|
-
|
-
|
1,306
|
||||||||||||
|
Net cash used in investing activities
|
(2,743
|
)
|
(1,621
|
)
|
(8,910
|
)
|
(2,282
|
)
|
||||||||
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||||||||||
|
Repayments of long-term loans
|
(473
|
)
|
(504
|
)
|
(1,560
|
)
|
(1,454
|
)
|
||||||||
|
Proceeds from issuance of ordinary shares and exercise of underwriters’ option
|
-
|
9,923
|
48,550
|
9,923
|
||||||||||||
|
Issuance costs of ordinary shares and exercise of the underwriters' option
|
(362
|
)
|
-
|
(3,182
|
)
|
-
|
||||||||||
|
Net change in short term loans from banks
|
-
|
(10,072
|
)
|
(4,350
|
)
|
(9,404
|
)
|
|||||||||
|
Net cash provided by (used in) financing activities
|
(835
|
)
|
(653
|
)
|
39,458
|
(935
|
)
|
|||||||||
|
Net increase (decrease) in cash and cash equivalents and restricted cash
|
3,917
|
516
|
39,957
|
(8,074
|
)
|
|||||||||||
|
Cash and cash equivalents and restricted cash at beginning of period
|
43,474
|
8,352
|
7,434
|
16,942
|
||||||||||||
|
Cash and cash equivalents and restricted cash at the end of period
|
$
|
47,391
|
$
|
8,868
|
$
|
47,391
|
$
|
8,868
|
||||||||
|
Supplementary information on investing and financing activities not involving cash flows:
|
||||||||||||||||
|
Additions of operating lease right-of-use assets and operating lease liabilities
|
1,948
|
$
|
228
|
3,783
|
$
|
818
|
||||||||||
|
Reclassification between inventory and property, plant and Equipment
|
-
|
-
|
579
|
60
|
||||||||||||
|
Supplemental disclosure of cash flow information:
|
||||||||||||||||
|
Interest paid
|
430
|
437
|
946
|
1,289
|
||||||||||||
|
Income taxes paid
|
21
|
-
|
197
|
-
|
||||||||||||
|
Three months ended
|
Nine months ended
|
|||||||||||||||
|
September 30,
|
September 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Net income
|
$
|
4,841
|
$
|
2,865
|
$
|
12,096
|
$
|
7,592
|
||||||||
|
Adjustments:
|
||||||||||||||||
|
Share in results and sale of equity investment of affiliated companies
|
(372
|
)
|
(169
|
)
|
(983
|
)
|
(601
|
)
|
||||||||
|
Taxes on income (tax benefit)
|
821
|
15
|
1,624
|
(94
|
)
|
|||||||||||
|
Financial expenses, net
|
(30
|
)
|
735
|
1,128
|
1,491
|
|||||||||||
|
Depreciation and amortization
|
1,334
|
1,565
|
4,025
|
4,463
|
||||||||||||
|
Share based compensation
|
167
|
21
|
680
|
210
|
||||||||||||
|
Adjusted EBITDA
|
$
|
6,761
|
$
|
5,032
|
$
|
18,570
|
$
|
13,061
|
||||||||